Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:PNFP News 29 December 2025 - 3 January 2026

UiPath (PATH) stock slides after CEO share sale filing as S&P MidCap 400 entry takes effect

UiPath (PATH) stock slides after CEO share sale filing as S&P MidCap 400 entry takes effect

UiPath shares fell nearly 3% to $15.88 in heavy trading Friday, their first session as an S&P MidCap 400 stock. CEO Daniel Dines sold 45,000 shares on Jan. 2 under a pre-arranged plan, according to a regulatory filing. The stock traded between $15.50 and $16.85, with about 44.1 million shares changing hands. Traders are watching for index-related flows and key U.S. economic data next week.
3 January 2026
···
UiPath stock set for Jan. 2 open after CEO share sale, S&P MidCap 400 entry looms (PATH)

UiPath stock set for Jan. 2 open after CEO share sale, S&P MidCap 400 entry looms (PATH)

UiPath shares closed at $16.39, down 1.7% on Dec. 31, after CEO Daniel Dines sold 90,000 shares for about $1.5 million under a pre-set plan, a filing showed. The company is set to join the S&P MidCap 400 before Friday’s open, replacing Synovus Financial. Shares last traded at $16.34 after hours. U.S. markets were closed Thursday for New Year’s Day.
2 January 2026
····
Pinnacle Financial (PNFP) stock: Nasdaq halt set for Jan. 2 as Synovus merger shifts shares to NYSE

Pinnacle Financial (PNFP) stock: Nasdaq halt set for Jan. 2 as Synovus merger shifts shares to NYSE

Nasdaq will suspend trading of Pinnacle Financial Partners (PNFP, PNFPP) on Jan. 2 as its merger with Synovus takes effect. Pinnacle shares last closed at $95.41, down 2.6%, on Dec. 31. The new holding company will list on the NYSE under the PNFP ticker. The Federal Reserve approved the deal, which was valued at $8.6 billion when announced in July.
1 January 2026
··
UiPath stock today is flat — what PATH investors are watching before the S&P MidCap 400 add

UiPath stock today is flat — what PATH investors are watching before the S&P MidCap 400 add

UiPath shares hovered near $16.84 Monday afternoon after fluctuating between $16.37 and $17.35. The company is set to join the S&P MidCap 400 on Jan. 2, replacing Synovus Financial, which is being acquired by Pinnacle Financial Partners. CEO Daniel Dines sold 90,000 shares last week under a pre-arranged plan. The iShares Expanded Tech-Software ETF slipped about 0.5%.
29 December 2025
···

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop